Harnessing oncolytic viruses for cancer immunotherapy to improve treatment outcomes

Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target malignant cells while sparing normal tissues.

Only One Harm From mRNA COVID Vaccines, Report Determines

Independent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and myocarditis, and also determined that, more broadly, intramuscular shots can cause a

April 17, 2024

Bridging the gap: Postnatal research offers clues to tackling maternal obesity

Postnatal dietary patterns, physical activity status, and changes in body weight among obese women living in a highly deprived region in the UK.

September 1, 2023

e-therapeutics announces completion of £28.90 million fundraise – Biotech Investments

JP Jenkins Ltd e-therapeutics announces completion of £28.90 million fundraise 03-Jul-2024 / 11:49 GMT/BST The issuer is solely responsible for the content of this announcement.

July 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.